Zobrazeno 1 - 10
of 1 273
pro vyhledávání: '"A. Passardi"'
Autor:
Stefano, Mauro, Perrina, Daniele, Vallicelli, Carlo, Ansaloni, Luca, Fugazzola, Paola, Coccolini, Federico, Agnoletti, Vanni, Frassineti, Giovanni Luca, Passardi, Alessandro, Tamberi, Stefano, Framarini, Massimo, Tassinari, Davide, Matteucci, Laura, Sturaro, Chiara, Gallo, Graziana, Catena, Fausto
Publikováno v:
In Journal of Gastrointestinal Surgery July 2024 28(7):1185-1193
Autor:
Sullo, Francesco Giulio1 (AUTHOR) francesco.sullo@irst.emr.it, Passardi, Alessandro1 (AUTHOR) alessandro.passardi@irst.emr.it, Gallio, Chiara1 (AUTHOR) alessandro.bittoni@irst.emr.it, Molinari, Chiara2 (AUTHOR) chiara.molinari@irst.emr.it, Marisi, Giorgia2 (AUTHOR) giorgia.marisi@irst.emr.it, Pozzi, Eleonora3 (AUTHOR) leonardo.solaini2@unibo.it, Solaini, Leonardo3 (AUTHOR), Bittoni, Alessandro1 (AUTHOR)
Publikováno v:
Journal of Clinical Medicine. May2024, Vol. 13 Issue 9, p2562. 20p.
Autor:
Germani, M.M., Vetere, G., Santamaria, F., Intini, R., Ghelardi, F., Bensi, M., Boccaccino, A., Minelli, A., Carullo, M., Ciracì, P., Passardi, A., Santucci, S., Giampieri, R., Persano, M., Fenocchio, E., Puccini, A., Lonardi, S., Pietrantonio, F., Salvatore, L., Cremolini, C.
Publikováno v:
In ESMO Open April 2024 9(4)
Publikováno v:
Dermatology Reports (2024)
Reticulate pigmentary disorders can be classified into inherited or acquired and cutaneous drug- induced reticulate hyperpigmentation belongs to this last group. The list of the drugs involved is constantly increasing and chemotherapy agents are freq
Externí odkaz:
https://doaj.org/article/71fcd068c15e43efb70c99fad421053a
Autor:
Giorgia Marisi, Irene Azzali, Alessandro Passardi, Francesca Rebuzzi, Giulia Bartolini, Milena Urbini, Matteo Canale, Chiara Molinari, Laura Matteucci, Francesco Giulio Sullo, Silvia Angela Debonis, Chiara Gallio, Graziana Gallo, Giovanni Luca Frassineti, Paola Ulivi
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract Bevacizumab (Bev) plus chemotherapy is a standard first-line treatment in metastatic colorectal cancer (mCRC), however to date no predictive factors of response have been identified. Results of our previous analysis on patients enrolled in a
Externí odkaz:
https://doaj.org/article/5cd50be5ac614657802f9ea9af386002
Autor:
Granato, Anna Maria, Pancisi, Elena, Piccinini, Claudia, Stefanelli, Monica, Pignatta, Sara, Soldati, Valentina, Carloni, Silvia, Fanini, Francesca, Arienti, Chiara, Bulgarelli, Jenny, Tazzari, Marcella, Scarpi, Emanuela, Passardi, Alessandro, Tauceri, Francesca, La Barba, Giuliano, Maimone, Giuseppe, Baravelli, Stefano, de Rosa, Francesco, Ridolfi, Laura, Petrini, Massimiliano
Publikováno v:
In Cytotherapy July 2024
Publikováno v:
Cancers, Vol 16, Iss 12, p 2190 (2024)
Colorectal cancer (CRC) ranks third in frequency among cancers diagnosed in males and second in females [...]
Externí odkaz:
https://doaj.org/article/e3abcba3d1594cb3a445546bcb01fb09
Autor:
Francesco Giulio Sullo, Alessandro Passardi, Chiara Gallio, Chiara Molinari, Giorgia Marisi, Eleonora Pozzi, Leonardo Solaini, Alessandro Bittoni
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 9, p 2562 (2024)
Rectal cancer presents a significant burden globally, often requiring multimodal therapy for locally advanced cases. Long-course chemoradiotherapy (LCRT) and short-course radiotherapy (SCRT) followed by surgery have been conventional neoadjuvant appr
Externí odkaz:
https://doaj.org/article/c1f3b2250642483881aabf33e85bec71
Autor:
Ivan Vannini, Tania Rossi, Mattia Melloni, Martina Valgiusti, Milena Urbini, Alessandro Passardi, Giulia Bartolini, Chiara Gallio, Irene Azzali, Sara Bandini, Valentina Ancarani, Lorenzo Montanaro, Giovanni Luca Frassineti, Francesco Fabbri, Ilario Giovanni Rapposelli
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 29, Iss , Pp 473-482 (2023)
The identification of predictive factors for treatment of pancreatic cancer (PC) is an unmet clinical need. In the present work, we analyzed blood-derived extracellular vesicles (EVs) from patients with advanced PC in order to find a molecular signat
Externí odkaz:
https://doaj.org/article/f4b2d8528b39499baa2321b0ae8b0da0
Autor:
Alessandro Passardi, Irene Azzali, Alessandro Bittoni, Giorgia Marisi, Francesca Rebuzzi, Chiara Molinari, Giulia Bartolini, Laura Matteucci, Francesco Giulio Sullo, Silvia Angela Debonis, Chiara Gallio, Manlio Monti, Martina Valgiusti, Margherita Muratore, Ilario Giovanni Rapposelli, Paola Ulivi, Giovanni Luca Frassineti
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 15 (2023)
Background: Validated predictors of sensitivity or resistance to Bevacizumab (Bev) are not available, and Inflammatory Indexes (IIs) has been reported to be useful prognostic factors in various malignant solid tumours, including metastatic colorectal
Externí odkaz:
https://doaj.org/article/7c76b2cc5c08402fb671d3dfe99c2c81